Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:clinical_trial
|
| gptkbp:completedIn |
June 2011
|
| gptkbp:condition |
Non-squamous Non-small Cell Lung Cancer
|
| gptkbp:enrollment |
1043
|
| https://www.w3.org/2000/01/rdf-schema#label |
NCT00403767
|
| gptkbp:intervention |
gptkb:Bevacizumab
gptkb:Carboplatin gptkb:Paclitaxel |
| gptkbp:location |
gptkb:Australia
gptkb:Canada gptkb:Europe gptkb:United_States |
| gptkbp:period |
Phase 3
|
| gptkbp:result |
Overall survival
Progression-free survival |
| gptkbp:sponsor |
gptkb:Hoffmann-La_Roche
|
| gptkbp:startDate |
December 2006
|
| gptkbp:status |
Completed
|
| gptkbp:studyType |
Interventional
|
| gptkbp:title |
A Study of Avastin (Bevacizumab) in Combination With Paclitaxel and Carboplatin in Patients With Advanced or Recurrent Non-squamous Non-small Cell Lung Cancer
|
| gptkbp:bfsParent |
gptkb:ROCKET_trial
|
| gptkbp:bfsLayer |
7
|